Anlon Healthcare's Ambitious IPO Set to Fuel Expansion

Anlon Healthcare Limited prepares to launch its IPO on August 26, 2025, targeting ₹121.03 Crores. Funds will expand production capabilities, repay debts, and support business growth. Allocations include 75% for Qualified Institutional Buyers, 15% for Non-Institutional Investors, and 10% for Individual Investors, with shares to be listed on NSE and BSE.

Anlon Healthcare Limited is gearing up to unveil its Initial Public Offering (IPO) on August 26, 2025. The chemical manufacturing firm aims to raise ₹121.03 Crores at the upper price bracket, with its shares scheduled for listing on both the NSE and BSE.

The issue encompasses 1,33,00,000 equity shares, each carrying a face value of ₹10 and priced between ₹86 and ₹91. Allocations are set for 75% to Qualified Institutional Buyers, 15% to Non-Institutional Investors, and the remaining 10% for Individual Investors.

The generated funds will bolster the construction of a new manufacturing facility, repay existing secured borrowings, enhance working capital, and address general corporate purposes. Interactive Financial Services Limited leads as the Book Running Lead Manager, with KFinTechnologies Limited as the Registrar. This financial maneuver has been designed to elevate Anlon's production bandwidth and secure its position within the industry's value chain.

(With inputs from agencies.)